45030 Federal Register / Vol. 82, No. 186 / Wednesday, September 27, 2017 / Notices 

benefits and services described in the 

State Plan. 

ORR proposes adding language to 

clarify the following requirements 

related to the Unaccompanied Refugee 

Minors (URM) program: State policy on 

education and training vouchers, 

medical coverage, the location of URM 

providers, monitoring procedures, the 

process for establishing legal 

responsibility, and information about 

sub-contractors. 

States must use a pre-print format for 

required components of State Plans for 

ORR-funded refugee resettlement 

services and benefits prepared by the 

Office of Refugee Resettlement (ORR) of 

the Administration for Children and 

Families (ACF). 

States must submit by August 15 each 

year new or amended State Plan for the 

next Federal fiscal year. For previously 

approved plan, States must certify no 

later than October 31 each year that the 

approved State plan is current and 

continues in effect. 

Respondents: State Agencies, the 

District of Columbia, Replacement 

Designees under 45 CFR 400.301(c), and 

Wilson-Fish Grantees (State 2 Agencies) 

administering or supervising the 

administration of programs under Title 

IV of the Act. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Title IV State Plan ............................................................................................ 57 1 15 855 

Estimated Total Annual Burden 

Hours: 855. 

Copies of the proposed collection may 

be obtained by writing to the 

Administration for Children and 

Families, Office of Planning, Research 

and Evaluation, 330 C Street SW., 

Washington, DC 20201. Attention 

Reports Clearance Officer. All requests 

should be identified by the title of the 

information collection. Email address: 

infocollection@acf.hhs.gov. 

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Email: OIRA_

SUBMISSION@OMB.EOP.GOV, Attn: 

Desk Officer for the Administration for 

Children and Families. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2017–20649 Filed 9–26–17; 8:45 am] 

BILLING CODE 4184–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Community Living 

Agency Information Collection 

Activities; Proposed Collection; Public 

Comment Request; Revision of a 

Currently Approved Information 

Collection (ICR–Rev) (OMB Approval 

Number 0985–0004); Title III 

Supplemental Form to the Financial 

Status Report (SF–425) 

AGENCY: Administration for Community 

Living, HHS. 

ACTION: Notice. 

SUMMARY: The Administration for 

Community Living (ACL) is announcing 

that the proposed collection of 

information listed above has been 

submitted to the Office of Management 

and Budget (OMB) for review and 

clearance as required under section 

506(c)(2)(A) of the Paperwork Reduction 

Act of 1995 (the PRA). This 30-day 

notice requests comments on the 

information collection requirements 

related to the proposed revision of an 

existing data collection regarding the 

information collection requirements in 

the Title III Supplemental Form to the 

Financial Status Report for all ACL/AoA 

Title III Grantees. 

DATES: Submit written or electronic 

comments on the collection of 

information by October 27, 2017. 

ADDRESSES: Submit written comments 

on the collection of information: by fax 

at 202.395.5806 or by email to OIRA_

submission@omb.eop.gov, Attn: OMB 

Desk Officer for ACL. 

FOR FURTHER INFORMATION CONTACT: 

Jesse Moore at (202) 795–7578 or 

Jesse.Moore@acl.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with Section 44 U.S.C. 

3507, ACL has submitted the following 

proposed collection of information to 

OMB for review and clearance. ACL is 

requesting approval for three years of an 

extension of the currently approved data 

collection with modifications. 

The Title III Supplemental Form to 

the Financial Status Report (SF–425) is 

used by ACL/AoA for all grantees to 

obtain a more detailed understanding of 

how projects funded under Title III of 

the Older Americans Act (OAA) of 1965, 

as amended, are being administered, 

and to ensure compliance with 

legislative requirements, pertinent 

Federal regulations and other applicable 

instructions and guidelines issued by 

the ACL. The level of data detail 

necessary is not available through the 

SF–425 form. The Supplemental Form 

provides necessary details on nonfederal required match, administration 

expenditures, Older Relative Caregivers 

expenditures, and Long Term Care 

Ombudsman expenditures. 

In addition to renewing OMB 

approval of this data collection, minor 

changes are being proposed to it to 

reflect changes in statutory language 

that occurred as a result of the 2016 

reauthorization of the OAA. 

Specifically, the term ‘‘Grandparents 

Only’’ has been changed to ‘‘Older 

Relative Caregivers,’’ the new term in 

the OAA that describes this population 

of eligible service recipients. Similarly, 

the accompanying instructions for 

completing the Title III Supplemental 

Form to the Financial Status Report 

were also modified to include this same 

language. References in the Code of 

Federal Regulation (CFR) have been 

updated addressing financial reporting 

requirements and non-substantive 

technical edits have been made to the 

instructions. 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 186 / Wednesday, September 27, 2017 / Notices 45031 

Comments in Response to the 60 Day 

Federal Register Notice 

A 60-day notice was published in the 

Federal Register in Vol. 82, No. 117, pg. 

28068 on June 20, 2017. No comments 

were received. 

Annual Burden Estimates 

ACL estimates the burden of this 

collection of information as follows: 56 

State Units on Aging (SUA) respond 

semi-annually which have an average 

estimated burden of 2 hours per grantee 

for a total of 112 hours per submission. 

The proposed data collection tool may 

be found on the ACL Web site for 

review at: https://www.acl.gov/aboutacl/public-input. 

Respondent/data collection activity Number of 

respondents 

Responses 

per 

respondent 

Hours per 

response 

Total annual 

burden hours 

Title III Supplemental Form to the Financial Status Report ............................ 56 2/yr 2 224 

Total .......................................................................................................... 56 2/yr 2 224 

Dated: September 19, 2017. 

Mary Lazare, 

Principal Deputy Administrator. 

[FR Doc. 2017–20666 Filed 9–26–17; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2017–N–0001] 

Advisory Committee; National 

Mammography Quality Assurance 

Advisory Committee; Renewal 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; renewal of advisory 

committee. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

renewal of the National Mammography 

Quality Assurance Advisory Committee 

by the Commissioner of Food and Drugs 

(the Commissioner). The Commissioner 

has determined that it is in the public 

interest to renew the National 

Mammography Quality Assurance 

Advisory Committee for an additional 2 

years beyond the charter expiration 

date. The new charter will be in effect 

until July 7, 2019. 

DATES: Authority for the National 

Mammography Quality Assurance 

Advisory Committee will expire on July 

7, 2017, unless the Commissioner 

formally determines that renewal is in 

the public interest. 

FOR FURTHER INFORMATION CONTACT: Sara 

Anderson, Office of Device Evaluation, 

Center for Devices and Radiological 

Health, Food and Drug Administration, 

10903 New Hampshire Ave., Bldg. 66, 

Rm. G616, Silver Spring, MD 20993– 

0002, 301–796–7047, Sara.Anderson@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to 41 CFR 102–3.65 and approval by the 

Department of Health and Human 

Services (HHS) pursuant to 45 CFR part 

11 and by the General Services 

Administration, FDA is announcing the 

renewal of the National Mammography 

Quality Assurance Advisory Committee 

(Committee). The Committee is a nondiscretionary Federal advisory 

committee established to provide advice 

to the Commissioner. The HHS 

Secretary and, by delegation, the 

Assistant Secretary for the Office of 

Public Health and Science and the 

Commissioner are charged with the 

administration of the Federal Food, 

Drug, and Cosmetic Act and various 

provisions of the Public Health Service 

Act. The Mammography Quality 

Standards Act of 1992 amends the 

Public Health Service Act to establish 

national uniform quality and safety 

standards for mammography facilities. 

The Committee advises the HHS 

Secretary and, by delegation, the 

Commissioner in discharging their 

responsibilities with respect to 

establishing a mammography facilities 

certification program. The Committee 

shall advise FDA on: 

• Developing appropriate quality 

standards and regulations for 

mammography facilities; 

• Developing appropriate standards 

and regulations for bodies accrediting 

mammography facilities under this 

program; 

• Developing regulations with respect 

to sanctions; 

• Developing procedures for 

monitoring compliance with standards; 

• Establishing a mechanism to 

investigate consumer complaints; 

• Reporting new developments 

concerning breast imaging which should 

be considered in the oversight of 

mammography facilities; 

• Determining whether there exists a 

shortage of mammography facilities in 

rural and health professional shortage 

areas and determining the effects of 

personnel on access to the services of 

such facilities in such areas; 

• Determining whether there will 

exist a sufficient number of medical 

physicists after October 1, 1999; and 

• Determining the costs and benefits 

of compliance with these requirements. 

The Committee shall consist of a core 

of 15 members, including the Chair. 

Members and the Chair are selected by 

the Commissioner or designee from 

among physicians, practitioners, and 

other health professionals, whose 

clinical practice, research 

specialization, or professional expertise 

includes a significant focus on 

mammography. Members will be invited 

to serve for overlapping terms of up to 

4 years. Almost all non-Federal 

members of this Committee serve as 

Special Government Employees. The 

core of voting members shall include at 

least four individuals from among 

national breast cancer or consumer 

health organizations with expertise in 

mammography, and at least two 

practicing physicians who provide 

mammography services. In addition to 

the voting members, the Committee 

shall include two nonvoting industry 

representatives who have expertise in 

mammography equipment. The 

Committee may include one technically 

qualified member, selected by the 

Commissioner or designee, who is 

identified with consumer interests. 

Further information regarding the 

most recent charter and other 

information can be found at https://

www.fda.gov/AdvisoryCommittees/ 

CommitteesMeetingMaterials/RadiationEmittingProducts/National

MammographyQualityAssurance

AdvisoryCommittee/ucm520365.htm or 

by contacting the Designated Federal 

Officer (see FOR FURTHER INFORMATION

CONTACT). In light of the fact that no 

change has been made to the Committee 

name or description of duties, no 

amendment will be made to 21 CFR 

14.100. 

This document is issued under the 

Federal Advisory Committee Act (5 

U.S.C. app.). For general information 

related to FDA advisory committees, 


asabaliauskas on DSKBBXCHB2PROD with NOTICES